Proteomic Analysis Identifies Protein Targets Responsible for Depsipeptide Sensitivity in Tumor Cells
Authors:
- 13 June 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 7 (7) , 2733-2742
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- HDAC inhibitors: Clinical update and mechanism-based potentialBiochemical Pharmacology, 2007
- Actions of a Histone Deacetylase Inhibitor NSC3852 (5-Nitroso-8-quinolinol) Link Reactive Oxygen Species to Cell Differentiation and Apoptosis in MCF-7 Human Mammary Tumor CellsThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Acetylation and deacetylation of non-histone proteinsGene, 2005
- Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A ReviewMolecular Pharmacology, 2005
- Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitorsProceedings of the National Academy of Sciences, 2005
- Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitorsProceedings of the National Academy of Sciences, 2005
- Marker genes to predict sensitivity to FK228, a histone deacetylase inhibitorBiochemical Pharmacology, 2004
- Apoptotic and autophagic cell death induced by histone deacetylase inhibitorsProceedings of the National Academy of Sciences, 2004
- The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxinProceedings of the National Academy of Sciences, 2002
- Modulation of p53, ErbB1, ErbB2, and Raf-1 Expression in Lung Cancer Cells by Depsipeptide FR901228JNCI: Journal of the National Cancer Institute, 2002